CLINICAL_TRIALS
trial_result
· 2021-11-10
Clinical Trial Update: Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis [Phase 4]
Summary
Phase 4 trial investigating intracameral moxifloxacin as prophylaxis for open-globe endophthalmitis in trauma-related eye injuries.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Federal University of São Paulo | Conditions: Endophthalmitis, Trauma, Corneal | Phase 4 | Status: UNKNOWN